Atyr Pharma Stock Price Prediction
LIFE Stock | USD 1.59 0.02 1.24% |
Oversold Vs Overbought
51
Oversold | Overbought |
aTyr Pharma stock price prediction is an act of determining the future value of ATyr Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of ATyr Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of ATyr Pharma and does not consider all of the tangible or intangible factors available from ATyr Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with aTyr Pharma, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of ATyr Pharma based on different types of headlines from major news networks to social media. The ATyr stock price prediction module provides an analysis of price elasticity to changes in media outlook on ATyr Pharma over a specific investment horizon. Using ATyr Pharma hype-based prediction, you can estimate the value of aTyr Pharma from the perspective of ATyr Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in ATyr Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in ATyr Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ATyr because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ATyr Pharma after-hype prediction price | USD 1.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ATyr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ATyr Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ATyr Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of ATyr Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ATyr Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ATyr Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
ATyr Pharma Estimiated After-Hype Price Volatility
In the context of predicting ATyr Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ATyr Pharma's historical news coverage. ATyr Pharma's after-hype downside and upside margins for the prediction period are 0.08 and 6.40, respectively. We have considered ATyr Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ATyr Pharma is dangerous at this time. Analysis and calculation of next after-hype price of aTyr Pharma is based on 3 months time horizon.
ATyr Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ATyr Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATyr Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ATyr Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 4.81 | 0.00 | 0.03 | 0 Events / Month | 5 Events / Month | Uncertain |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.59 | 1.59 | 0.00 |
|
ATyr Pharma Hype Timeline
aTyr Pharma is now traded for 1.59. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. ATyr is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.2%. %. The volatility of related hype on ATyr Pharma is about 3607.5%, with the expected price after the next announcement by competition of 1.56. About 62.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. aTyr Pharma recorded a loss per share of 0.94. The entity last dividend was issued on the 1st of July 2019. The firm had 1:14 split on the 1st of July 2019. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out ATyr Pharma Basic Forecasting Models to cross-verify your projections.ATyr Pharma Related Hype Analysis
Having access to credible news sources related to ATyr Pharma's direct competition is more important than ever and may enhance your ability to predict ATyr Pharma's future price movements. Getting to know how ATyr Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ATyr Pharma may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
MREO | Mereo BioPharma Group | (0.02) | 8 per month | 0.00 | (0.04) | 7.69 | (6.07) | 21.23 | |
TERN | Terns Pharmaceuticals | (0.27) | 7 per month | 0.00 | (0.05) | 8.64 | (8.38) | 27.76 | |
PDSB | PDS Biotechnology Corp | 0.00 | 0 per month | 0.00 | (0.13) | 7.51 | (9.16) | 26.33 | |
INZY | Inozyme PharmaInc | (0.35) | 8 per month | 4.48 | 0.04 | 8.83 | (8.42) | 25.32 | |
HOOK | Hookipa Pharma | 0.00 | 0 per month | 3.16 | 0.06 | 6.25 | (6.17) | 24.40 | |
XFOR | X4 Pharmaceuticals | 0.28 | 8 per month | 4.14 | 0.11 | 10.47 | (7.00) | 35.23 | |
DAWN | Day One Biopharmaceuticals | (0.57) | 12 per month | 3.31 | 0.03 | 5.46 | (4.70) | 20.03 | |
ABOS | Acumen Pharmaceuticals | (0.31) | 9 per month | 0.00 | (0.03) | 7.28 | (6.35) | 23.58 | |
AMLX | Amylyx Pharmaceuticals | 0.04 | 5 per month | 0.00 | (0.15) | 6.96 | (8.30) | 103.39 |
ATyr Pharma Additional Predictive Modules
Most predictive techniques to examine ATyr price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ATyr using various technical indicators. When you analyze ATyr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About ATyr Pharma Predictive Indicators
The successful prediction of ATyr Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as aTyr Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ATyr Pharma based on analysis of ATyr Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ATyr Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ATyr Pharma's related companies. Story Coverage note for ATyr Pharma
The number of cover stories for ATyr Pharma depends on current market conditions and ATyr Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ATyr Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ATyr Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
ATyr Pharma Short Properties
ATyr Pharma's future price predictability will typically decrease when ATyr Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of aTyr Pharma often depends not only on the future outlook of the potential ATyr Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 53.6 M | |
Cash And Short Term Investments | 98.2 M |
Check out ATyr Pharma Basic Forecasting Models to cross-verify your projections. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.